Novo Nordisk CEO on Wegovy pill's U.S. future as Iran war threatens supply chains

<p>Novo Nordisk CEO Mike Doustdar sits down with CNN to discusses manufacturing the Wegovy pill in the U.S, direct to consumer weightloss drugs, competition with rivals like Eli Lilly and how the impact of the Iran war could affect global drug supply.</p>